Lévi, F., Karaboué, A., Saffroy, R., Desterke, C., Boige, V., Smith, D., . . . Lemoine, A. (2017). Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). Br J Cancer.
Stile di citazione ChicagoLévi, Francis, et al. "Pharmacogenetic Determinants of Outcomes On Triplet Hepatic Artery Infusion and Intravenous Cetuximab for Liver Metastases From Colorectal Cancer (European Trial OPTILIV, NCT00852228)." Br J Cancer 2017.
Citazione MLALévi, Francis, et al. "Pharmacogenetic Determinants of Outcomes On Triplet Hepatic Artery Infusion and Intravenous Cetuximab for Liver Metastases From Colorectal Cancer (European Trial OPTILIV, NCT00852228)." Br J Cancer 2017.